Cardiovascular outcomes after percutaneous coronary intervention on bifurcation lesions with moderate to severe coronary calcium: Asingle-centerregistry study

被引:4
作者
Murphy, Jonathan Luke
Patel, Nileshkumar
Vengrenyuk, Yuliya
Okamoto, Naotaka
Barman, Nitin
Sweeny, Joseph
Kapur, Vishal
Hasan, Choudhury
Krishnan, Prakash
Vijay, Pooja
Jhaveri, Vaishvi
Dangas, George
Mehran, Roxana
Aquino, Melissa
Baber, Usman
Sharma, Samin K.
Kini, Annapoorna S.
机构
[1] Mt Sinai Hosp, Cardiovasc Inst, New York, NY 10029 USA
[2] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
关键词
bifurcation lesion; coronary calcification; percutaneous coronary intervention; DRUG-ELUTING STENTS; ACUTE MYOCARDIAL-INFARCTION; DUAL ANTIPLATELET THERAPY; ARTERY-DISEASE; ROTATIONAL ATHERECTOMY; HARMONIZING OUTCOMES; CLINICAL-OUTCOMES; POOLED ANALYSIS; REVASCULARIZATION; IMPACT;
D O I
10.1002/ccd.29069
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Both target vessel calcification and target vessel bifurcation are associated with worse outcomes following percutaneous coronary intervention (PCI). Whether these entities in combination interact to influence outcomes after PCI of complex coronary disease is not known. Objectives This study evaluated the association of target vessel bifurcation and target vessel calcification, alone and in combination, with adverse events following PCI. Methods Registry data from 21,165 patients who underwent PCI with drug-eluting stents (DES) between January 2009 and December 2017 were analyzed. Patients were divided into four groups according to the presence or absence of target vessel bifurcation and presence of none/mild or moderate/severe target vessel calcification on angiography. Associations between lesion groups and 1 year major adverse cardiac events (MACE) were examined using Cox regression analysis. Results At 1 year, unadjusted rates of MACE, death, myocardial infarction (MI), as well as stent thrombosis were highest in the group with both bifurcation lesion and moderate/severe calcification. After adjusting for confounders such as age, renal disease, and smoking, hazard ratios for MACE were 1.14 (95%CI 0.99-1.33) for bifurcation with none/mild calcification, 1.21 (95%CI 1.06-1.38) for no bifurcation and moderate/severe calcification, and 1.37 (95%CI 1.14-1.64) for bifurcation and moderate severe calcification, compared to patients with no bifurcation and none/mild calcification. Conclusions The presence of a bifurcating target vessel with moderate/severe calcification is associated with a higher risk of adverse outcomes than either attribute alone. New approaches are needed to improve outcomes in this subset of patients with complex coronary artery disease.
引用
收藏
页码:35 / 42
页数:8
相关论文
共 50 条
  • [21] Two-year outcomes after percutaneous coronary intervention of calcified lesions with drug-eluting stents
    Genereux, Philippe
    Redfors, Bjorn
    Witzenbichler, Bernhard
    Arsenault, Marie-Pier
    Weisz, Giora
    Stuckey, Thomas D.
    Rinaldi, Michael J.
    Neumann, Franz-Josef
    Metzger, D. Christopher
    Henry, Timothy D.
    Cox, David A.
    Duffy, Peter L.
    Mazzaferri, Ernest L., Jr.
    Francese, Dominic P.
    Marquis-Gravel, Guillaume
    Mintz, Gary S.
    Kirtane, Ajay J.
    Maehara, Akiko
    Mehran, Roxana
    Stone, Gregg W.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 231 : 61 - 67
  • [22] Impact of acute and persistent stent malapposition after percutaneous coronary intervention on adverse cardiovascular outcomes
    Lombardi, Marco
    Chiabrando, Juan G.
    Romagnoli, Enrico
    D'amario, Domenico
    Leone, Antonio M.
    Aurigemma, Cristina
    Montone, Rocco A.
    Ricchiuto, Alfredo
    Biondi-zoccai, Giuseppe
    Burzotta, Francesco
    Jang, Ik-Kyung
    Escaned, Javier
    Trani, Carlo
    Porto, Italo
    Crea, Filippo
    Vergallo, Rocco
    MINERVA CARDIOLOGY AND ANGIOLOGY, 2023, 71 (05) : 525 - 534
  • [23] Percutaneous coronary intervention for bifurcation coronary lesions: the 15th consensus document from the European Bifurcation Club
    Burzotta, Francesco
    Lassen, Jens Flensted
    Lefevre, Thierry
    Banning, Adrian P.
    Chatzizisis, Yiannis S.
    Johnson, Thomas William
    Ferenc, Miroslaw
    Rathore, Sudhir
    Albiero, Remo
    Pan, Manuel
    Darremont, Olivier
    Hildick-Smith, David
    Chieffo, Alaide
    Zimarino, Marco
    Louvard, Yves
    Stankovic, Goran
    EUROINTERVENTION, 2021, 16 (16) : 1307 - +
  • [24] Comparative Outcomes After Unprotected Left Main Stem Percutaneous Coronary Intervention
    Almudarra, Sami S.
    Gale, Chris P.
    Baxter, Paul D.
    Fleming, Sarah J.
    Brogan, Richard A.
    Ludman, Peter F.
    de Belder, Mark A.
    Curzen, Nick P.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2014, 7 (07) : 717 - 730
  • [25] Presence of Diabetes Does Not Matter for Percutaneous Coronary Intervention Outcomes With Simple Coronary Lesions Can That Be True?
    Ellis, Stephen G.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (20) : 2119 - 2120
  • [26] Impact of previous percutaneous coronary intervention on cardiovascular outcomes and mortality after lung cancer surgery: A nationwide study in Korea
    Yoon, Dong Woog
    Shin, Dong Wook
    Cho, Jong Ho
    Lee, Jong-Hwan
    Yang, Jeong Hoon
    Han, Kyungdo
    Park, Sang Hyun
    THORACIC CANCER, 2020, 11 (09) : 2517 - 2528
  • [27] Comparison of Adverse Outcomes After Contemporary Percutaneous Coronary Intervention in Women Versus Men With Acute Coronary Syndrome
    Pendyala, Lakshmana K.
    Torguson, Rebecca
    Loh, Joshua P.
    Kitabata, Hironori
    Minha, Sa'ar
    Badr, Salem
    Dvir, Danny
    Barbash, Israel M.
    Satler, Lowell F.
    Pichard, Augusto D.
    Waksman, Ron
    AMERICAN JOURNAL OF CARDIOLOGY, 2013, 111 (08) : 1092 - 1098
  • [28] Association Between Glycosylated Hemoglobin Level and Cardiovascular Outcomes in Diabetic Patients After Percutaneous Coronary Intervention
    Zheng, Jia
    Cheng, Jing
    Zhang, Qian
    Qi, Cuijuan
    Wang, Tong
    Xiao, Xinhua
    MEDICINE, 2016, 95 (19)
  • [29] Transfusion and clinical outcomes after percutaneous coronary intervention
    Choi, Jungmin
    Lee, Seung-Hwa
    Choi, Ki-Hong
    Lee, Joo Myung
    Park, Taek Kyu
    Yang, Jeong Hoon
    Song, Young Bin
    Hahn, Joo-Yong
    Choi, Seung-Hyuk
    Gwon, Hyeon-Cheol
    Choi, Jin-Ho
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [30] Polypharmacy and Bleeding Outcomes After Percutaneous Coronary Intervention
    Yamamoto, Ko
    Morimoto, Takeshi
    Natsuaki, Masahiro
    Shiomi, Hiroki
    Ozasa, Neiko
    Sakamoto, Hiroki
    Takeji, Yasuaki
    Domei, Takenori
    Tada, Takeshi
    Taniguchi, Ryoji
    Uegaito, Takashi
    Yamada, Miho
    Takeda, Teruki
    Eizawa, Hiroshi
    Suwa, Satoru
    Shirotani, Manabu
    Tamura, Toshihiro
    Inoko, Moriaki
    Sakai, Hiroshi
    Ishii, Katsuhisa
    Toyofuku, Mamoru
    Miki, Shinji
    Onodera, Tomoya
    Furukawa, Yutaka
    Inada, Tsukasa
    Ando, Kenji
    Kadota, Kazushige
    Nakagawa, Yoshihisa
    Kimura, Takeshi
    CIRCULATION JOURNAL, 2024, 88 (06)